In the three stage model of carcinogenesis in mouse skin, to a certain compartment of normal cells new and adverse biological properties are imposed by the initiator DMBA yielding 'potential tumor cells,' or 'initiated cells.' These initiated cells exhibit a selective advantage of growth over surrounding normal cells if exposed to DTE promoters. The new properties may result from a genomic mutation associated with an increase of density, affinity or cooperativity of certain membrane receptors as compared to normal cells. Complete promoters, such as TPA, but not incomplete promoters such as RPA may impose a second additional genomic or epigenomic insult onto initiated cells ('conversion'). As a consequence, initiated cells become ready to respond to unspecific mitogenic stimuli ('propagation'), as provided by hyperplasiogenic agents. The initiatiodpromotion model of mouse skin presents new and attractive possibilities to apply the oncogene approach for further in-depth analysis of the molecular mechanisms of its stages. It remains to be seen to what extent molecular events demonstrated causative for the stages in the mouse skin model are applicable also to stages in multistage models of chemical carcinogenesis operational in other target tissues. at SAGE PUBLICATIONS on December 9, 2012 tpx.sagepub.com Downloaded from Vol. 15, No. 2, 1987 SKIN CARCINOGENESIS 247 1 0 0 60 b I 1 0 8 6 4 2 0 t m e [weeks] time [weeks] INITIATION: 8-8 50 nmol DMBA +-.a-1 0 0 nmol trans-3.4-dihvdrodiol -A-A-400 nmol trons-8;9-dih;drodnoI -W-400 nmol trans-10.1 1 -dlhydrodlol +-3 400 nmol trans-5.6-dihydrodiol 50 -i o
INTRODUCTION
Carcinogenesis is a pathologic process of outmost biological complexity which may be mimicked in experimental models. By means of certain protocols for multifactorial carcinogenesis (27, 29) , the entire process may be subdivided in operationally defined singular subunits or stages. The subunits are of a more limited complexity and thus appropriate for qualitative and quantitative mechanistic investigations at the cellular and molecular levels (e.g., 28) . As a prototype process of cocarcinogenesis (for terminology see refs. 25, 27 and 29) , the three-stage model of initiatiodpromotiodprogression in mouse skin was fully established in experimental cancer research in the last about 15 years (Fig. 1) . Some additional recent results from our laboratory with regard to the stages of initiation and of promotion in mouse skin will be described subsequently and related to the entire process of carcinogenesis in this target tissue. Gradually, the results of analyses of its stages, as well as of similar stages in models oper-*Presented at the Third Sardinian International Symposium, October 6-9, 1985 in Cagliari, Italy.
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ational in other target tissues, such as liver, may lead to a better understanding of processes in chemical carcinogenesis at both the etiologic (e.g., 26, 27, 29, 32) as well as the mechanistic levels (e.g., 23, 24, 30, 31, 68, 69) .
The three stages of our model we generate routinely in the skin of female NMRI mice in a highly standardized protocol, using as initiator the solitary carcinogen 7,12-dimethylbenz[a]anthracene (DMBA) and as initiaton (or tumor) promoters cocarcinogens such as 12-0-tetradecanoylphorbol-13acetate (TPA) or other prototype diterpene esters (DTE) (Fig. 1) . Investigations in this model are still confined essentially to the operationally well defined stages of initiation and promotion, for which minimally effective doses (i.e., subcarcinogenic doses i and subpromotional doses p ) have been established for many years. Mechanistic explorations covering both stages in the organism, the cellular and molecular levels are guided by the results of investigations on structure-activity relationships ofthc initiators and promoters involved. -The prototype process of cocarcinogenesis in mouse skin in the special protocol of initiatiodpromotion with its three, operationally defined stages initiation, promotion and progression. One of the most advanced models for toxicokinetic and toxicodynamic investigations in chemical carcinogenesis. get molecules of the biochemically active entities identified, to trigger those molecular and biological sequences responsible for the phenotypic expression of tumors or cancers.
MECHANISTIC EVENTS IN THE STAGE OF INITIATION OF MOUSE SKIN BY

7,12-DIMETHYL-BENZ[A]ANTHRACENE
Generation of what may be called 'potential tumor cells' or simply 'initiated cells' in the target tissue is considered the characteristic key event in any (multifactorial) protocol of tumorigenesis or carcinogenesis (24, 34, 55) ( Fig. 1 ). In the mouse skin model, initiation by topical application of DMBA may be inhibited by inhibitors of the microsomal cytochrome P-450 dependent monooxygenase complex, such as 7,8-benzoflavone (BF). From these and other findings it was concluded that metabolism of DMBA by microsomal monooxygenases plays a crucial role for initiation of mouse skin (24, (56) (57) (58) (59) 71) . Qualitative and quantitative investigations on the metabolism of DMBA, administered topically or intragastrically, revealed a plethora of oxygenated metabolites occurring in the epidermis as well as in other organs (50-52,67,69). A target tissue specific metabolite has not become apparent. Together with the well estabIished fact that unchanged DMBA is not mutagenic (24, 71) , the results oftoxicokiiietic iiiwtigations (50-52, [56] [57] [58] [59] suggest that in the epidermis of NMRI mice, metabolic activation by enzymatic oxygenation takes place to provide highly reactive entities, or 'ultimate initiators' (18, 24) . These may bind covalently to informational macromolecules, such as protein, RNA and especially to genomic DNA (34, 55) .
In semiquantitative investigations on stnrctirreactirity refationships regarding initiation efficiency of many oxygenated DMBA derivatives (Fig. 2) , the DMBA-3,4-transdihydrodiol was the most active metabolite (1 8). DMBA-3,4-transdihydrodiol exhibits most interesting initiation-related biological activities: (a) in several short term assays where a variety of DMBA metabolites were potent mutagens, the most potent was DMBA-3,4-transdihydrodiol (71, 79) ; (b) the efficiency of DMBA-3,4transdihydrodiol to produce lung adenoma in newborn mice is comparable to that of DMBA (80) . Therefore, DNA-binding by the initiator DMBA may be confined to DMBA-3,4-transdihydrodiol as a 'proximate' and to the stereoisomers of DMBAtrans-3,4-dihydrodiol-1,2-oxides as 'ultimate initiators' (24, 69) . This hypothesis is amenable to further experimental validation.
Uqm5jic and S'pecijc Covalent Bindiiig of fW1tiinate) Initiators to DAM In our laboratory the highly sensitive 32P-postlabeling procedure (6 1) was considered to be the method of choice for sensitive determination of covalent DNA-binding of DMBA and DMBA metabolites in vivo (68, 69) . Such data may be related to our semiquantitative data on initiation efficiency in the same system.
Qualitatively, 18 hr after topical administration of i = 100 nmoles of DMBA (Table I) , the 32Ppostlabeling procedure led to four deoxyribonucleotide adducts in the 4D PEI cellulose mapping, each carrying a covalently bound, yet unidentified, derivative of DMBA. Similarly, topical exposure of skin to i = 400 nmoles of weakly initiating DMBA-8,9-dihydrodioI (Table I) DMBA. In contrast, the same dose i of non-initiating 7-OHM-12-MBA gave rise to two major adducts, separable from any of the DMBA-adducts. Exposure to i = 400 nmoles of each non-initiating 3-OH-DMBA and DMBA-0, did not lead to any detectable amounts of adducts. In contrast, at i = 100 nmoles (Table I) , DMBA-trans-3,4-dihydrodiol gave rise to four relatively intense spots, and a pattern qualitatively similar to that obtained with DMBA. More detailed tentative, qualitative correlations of the individual spots generated by all the DMBA-derivatives tested in the DNA-binding may be found elsewhere (69) .
For qiiaiititative comparisons of binding efficiencies, in independent experiments using two NMRI mice, the relative adduct level (RAL number of adducts per 1 O7 normal nucleotides) was determined for DMBA and selected metabolites (Table I) . As compared to the RAL from the acetone control (zero), DMBA at i = 100 nmoles produced a RAL of 12. At a four times higher dose, DMBA-8,9-dihydrodiol exhibited a RAL three to six times lower, and 7-OHM-12-MBA resulted in a RAL twofold higher than DMBA. With DMBA-trans-3,4-dihydrodiol, the RAL was seven to eight times higher than that achieved by the same i dose of DMBA.
The remarkable power of the DMBA-trans-3,4-dihydrodiol to bind to DNA becomes even more apparent, if the RAL is related to the initiating dose i (Table I, 
initiation specific RAL).
Tentative trials to characterize further the mixtures of deoxyribonucleotide adducts generated by DMBA and DMBA-3,4-dihydrodiol in chromatography of the four adducts expected in both cases a Initiator dose i (in nmoi/mouse) dissolved in 0.1 ml acetone, onto the shaved dorsal skin of NMRI-mice followed by standard promotion with p = 10 nmoles of TPA (35); T,: average tumor yield (tumors per survivor), read in the 18th week (18).
In each of the two experiments one NMRI-mouse was exposed to the initiator for 18 hours; DNA was isolated from the skin area exposed and analyzed according to the JZP-postlabeling procedure; spots were cut out from chromatograms and radioactivity was determined by Cerenkov assay; results as mcm values of three or four determinations -C SD and expressed as adducts per lo7 normal nucleotides.
Average of both experiments per 10' normal nucleotides/dose i. showed two spots with decreased mobility. Only these adducts were also sensitive to oxidation by periodate. This may suggest that the two sensitive DNA-adducts carry vicinal cis-hydroxyl groups in their deoxyribose moiety. Thus, it may be concluded that these adducts probably originate from binding of the aiiti-3,4-dihydrodio1-1 ,2-oxidesY whereas the other two adducts stem from the correspondingsyizstereoisomers (68, 69) . In comparison to DMBA, the lower tumor initiating efficiency of DMBA-3,4-dihydrodiolY associated with its higher efficiency in DNA binding, may appear surprising. However, the degree of overall biridiiigofany activated metabolite to DNA need not necessarily parallel its speccific iiiitiatiiig eficieiicy. For example, a small amount of an initiationspecific DNA-adduct, far below overall (non-specific aiid specific) binding of DMBA-3,4-dihydrodiol, may represent the critical biochemical or molecular event, such as mutations ofa proto-oncogene, yielding 'initiated cells' finally. Indeed, the overall formation of DNA-adducts cannot be correlated directly with initiation efficiency as was demonstrated for various other PAH recently (68) .
Specific Geiior ii ic Events Associated with Iiiitiatioii by DhlBA-An Oricogeiie Approach. In the last 10 years an interesting new aspect of initiation was unraveled by the finding that lymphoblastoid cells, carrying latent genomes of Epstein-Barr virus (EBV), such as Raji cells, may be stimulated by TPA iiz vitro to generate virus specific proteins or complete virus (24, 84, 85) . In the skin of a specific strain of rat, like the Mastoriiys natalemis, exposure to TPA iri viyo elicits papilloma within short latency periods and at high rates (2). In both cases, latent tumor virus may be considered some sort of a toxicodyiiainic siibstitiite of a cheriiical initiator. Hence, cells carrying DNA with tumor viral information, may be somehow related to 'initiated' cells (86) .
Using sophisticated molecular biology techniques, most interesting structural relationships between the DNA of certain tumor viruses and the DNA of certain genes of mammalian cells were detected, including proto-oncogenes or oncogenes (78) . By application to multistage protocols of the molecular biology techniques developed, the mutation hypothesis of solitary carcinogenesis, postulated already at the beginning of this century (7), finally is becoming amenable to experimental challenge. Thus, the genome of mammalian cells became accessible to experimentation at the molecular level for the first time. In contrast to the classical dogma that implied a highly static genomic structure-the cellular genome in fact exhibited considerable, but coiitrolled dyizantics (1 1). Thus in animal and human tumors, by molecular techniques a number of genes were identified, the expression of which was altered by translocation or mutation. In this regard, one of the most informative techniques is DNA transfection into NIH/3T3 cells. This technique guided the isolation of genes that have acquired the ability to confer the transformed phenotype on these cells ('transforming genes'). Most genes of this category are members of the ras family, comprising Harvey-(Ha-), Kirsten-(Ki-), and N-ras, but several other genes of this kind have been identified also (78) .
Recently, a series of DNA samples from tumors, obtained by initiation of mouse skin with DMBA followed by promotion with TPA was assayed in the transfection assay (3, 4) . A high percentage of the papillomas and carcinomas obtained in Sencar as well as in NMRI mice showed reproducibly an activated Harvey-ras oncogene (Ha-ras) ( Table 11 ). The Sencar strain was raised by selection and propagation to achieve mice particularly sensitive to the initiation/promotion protocol (6). These animals produce large papillomas, convenient for isolation of DNA. However, this strain may carry some kind of heritable (or viral) predisposition, substituting partially for initiation if high doses of TPA alone are employed. This makes interpretation of initiation-promotion experiments potentially difficult in this strain. On the other hand, the NMRI mouse is not particularly sensitive to either initiation by DMBA nor to promotion by TPA. Since a heritable predisposition apparently is non-existent, this strain, in general, is considered more appropriate as a host of initiation/promotion experiments in skin. The fact that Ha-ras was activated already in the premalignant stage suggests that the activation must have occurred in the initiation stage. Moreover, in over 90% of the tumors the Ha-ras gene showed a specific A -T transversion in the second nucleotide of codon 61. The frequency of this mutation was dependent on the initiating agent used (DMBA, MMNG), but not on the promoter, suggesting that the mutation occurs at the time of initiation (60) .
From the hypothesis that a ras gene mutation is critically involved in DMBA-induced initiation of mouse skin, it may be predicted that introduction of a mutated gene into epidermal cells in idvo could substitute for the initiator similarly as EBV and papilloma virus can (2, 24, 84, 85, 86) . When Harvey murine sarcoma virus (HaMSV) or BALB murine sarcoma virus (BALBMSV) mutated in codons 12 and 59, were applied directly to skin of NIH or Sencar mice, followed by treatment with TPA, papillomas developed after 4-5 weeks. Some of these papillomas subsequently progressed to carcinomas (8). No skin tumors were seen in the absence of promoter treatment. When taken together with the fact that the v-ras H gene is mutated at codons 12 and 59, in conjunction with the evidence for carcinogen-specific mutations in the c-Ha-ras gene, it lends strong support to the idea that the point mutation of the latter at codon 61 is an event critical in initiation (8). Both papillomas and carcinomas express virus-specific ras mRNA and the viral form of ras P21 protein. In most papillomas tested the mutation was heterozygous, but in some carcinomas it was homozygous or also amplified. The development of further chromosomal changes at the c-Haras gene locus therefore may be considered a common feature of the progression stage ( Fig. 1) (86) .
By necessity, the conclusions reached so far by the successful application of the oncogene approach to the initiation/promotion model of mouse skin may be oversimplistic and in some cases highly speculative. Yet, they may serve to focus attention on a set of innovative hypotheses which have became amenable to experimental testing at the mo-lecular level. For example, the molecular mechanisms as to how the DNA adducts, generated by DMBA derived 'ultimate initiators,' may elicit genomic activations and mutations, are presently under investigation in our laboratory.
MECHANISTIC EVENTS IN THE STAGE OF
DITERPENE ESTERS
A multitude of skin irritating diterpene esters (DTE) with initiation or tumor promoter properties, were detected in certain plant species. They may be related to only three principal (hypothetic) parent diterpene structures, including tigliane, daphnane and ingenane (23) . In the bioactive esters ( Fig. 3) , the parent diterpenes are polyfunctionalized to carry, besides certain ester groups, simple oxygen functions and double bonds, as exemplified by the structures of the prototype DTE irritants and promoters: TPA (33, simplexin [9,13,14-orthodecanoyl-5~hydroxy-6a,7a-epoxyresiniferonol] (82) , and 3-TI [3-O-tetradecanoylingenol] (74) (Fig. 3) . Their promoter dose p is remarkably low, i.e. less than 5 nmoles of DTE, and thus comparable to doses of proliferation stimulating hormones or growth factors (35) . In contrast to DTE, remarkably, the corresponding polyfunctional diterpene parent alcohols phorbol, resiniferonol and ingenol are inactive as irritants and as promoters (1, 23, 35, 76, 83) ( Fig.  3) . In addition to the DTE originating from plants, many DTE structures have been tailor-made by partial syntheses from the DTE parent alcohols to provide compounds most appropriate for investigations of toxicokinetics and of structure/activity relations (23, 42, 73, 74, 77) (Fig. 3) .
In many plant species the skin irritating DTE are present partially also in the form of polyfunctional oligo(mono-,di-)-20-esters. As a rule, they exhibit rather low irritancies on the mouse ear and pro-PROMOTION OF MOUSE SKIN BY HECKER TOXICOLOGIC PATHOLOGY moting activities on the back skin of NMRI mice.
Oligo-20-esters may be activated chemically as well as metabolically in target tissues by selective cleavage of the 20-ester group to become highly active mono-or diester promoters. Therefore, the low activity oligo-20-esters may be specified as 'cryptic irritants and promoters.' Metabolic investigations of the DTE prototype promoters, mainly on TPA and 3-TI ( Fig. 3) , indicate that cleavage of the lipophilic ester group essentially yields phorbol-13-acetate or ingenol, respectively. As they are inactive biologically, they may be considered products of metabolic deactivation. .The corresponding highly active oligoesters therefore are the 'ultimate irritants and, promoters'; they carry those moieties interacting directly with cellular target molecules to result in the promotion of 'initiated cells' (e.g., 23, 24, 28, 30, 3 1). From the toxicokineticpoiiit of view, the cryptic forms deserve particular attention as potential risk factors of human cancer (25, 26, 29, 32) .
Role in Bioactivity of Hydrophilic and Lipopltilic Functions in the Diterpene Moieties. As was shown in many studies of strticttire-actisity relationships
(1,23,35,76,83), a free primary hydroxyl function in position 20 is the most prominent Itydrophilic feattire in all imtant DTE promoters, including the protoypes TPA, simplexin and 3-TI (Fig. 3 ). This feature is essential for their biological activities (23) . Therefore, it may be postulated that the spatial position of this function, as determined by their particular carbon skeleton and relative to specifically binding cellular structures, may play a delicate role in the hydropliilic interaction of DTE promoters with membranes and receptors (23, 30, 31) . This hypothesis was corroborated recently using computer assisted molecular modelling of DTE (43, 44). To this end, three-dimensional computer graphs were made from the graphic display of x-ray data obtained previously for phorbol, mezerein and ingenol-3,5,20-triacetate. In painvise matching by common structural elements of the diterpene moieties, the quality of the fits was expressed quantitatively by the intermolecular distances calculated for corresponding atoms in the matched pairs ( Fig. 4) .
As a reference of atomic distances, the length of the regular C-C bond is used relative to which the intermolecular distance of corresponding atoms obtained in individual fits, may be compared (Table  111 ).
In this way two hypotheses have been verified consecutively (43, 44): 1. The diterpene moieties of phorbol, mezerein and ingenol-3,5,20-triacetate fit well if, as primary matching group, their common structural element carrying the primary hydroxyl function C6-(C20)-C7, is used (Table 111) .
2. The diterpene moieties fit even better ifas secondary matching groups, structural elements carrying other oxygen functions are used, such as C4-0 4 (Table 111) , and alternatively or in addition C9-0 9 , and C3-03.
Taking, for example, fit 2a from Table 111 , this would mean that both of the hydrophilic structural elements of the diterpene moieties fitted, C(6)-C(20)-C(7) and C4-04, may be considered important centers (a) of non-covalent binding to putative cellular target molecules (receptors) and, consequently, (b) of bioactivity. This proposition was tested in part already previously by synthetic efforts aiming at nonactive DTEs of closest possible structures, for use as most appropriate negative control compounds (23, 33 , such as the now widely used 4-OMe-TPA or 4a-PDD. A forecast by computer-assisted mo-lecular modelling of an active structure in the ingenol ester series was verified recently by means of partial synthesis of the predicted structure (44).
After part of our data had been presented (43), an approach of molecular modelling similar in principle and used for comparison of the TPA structure with teleocidin was published (41) .
DTE irritants and promoters, such as TPA, simplexin and 3-TI carry at least one lipophilic group, such as a long chain aliphatic ester moiety as a common lipophilic featirre (Fig. 3) . The ester bond is the primary site ofmetabolic deactivation (23) . The specific structure of the ester group determines the quality of the biological activities of the corresponding DTE (1, 23, 35, 76, 83) . Generally in mouse skin irritaiit (and hyperplasiogenic) activity are necessary, yet incoi~plete reqirireiiietits for proiiiotiiig activity. (23, 31, 47) .
Indeed, and not unexpectedly, it turned out that the Euphorbia factor Ti, or the synthetic (73, 77) 12-0-retinoylphorbol-13-acetate (RPA) are irritant and hyperplasiogenic agents practically as active as TPA or Ti, (Fig. 5 ). Yet, in the standardized initiation-promotion protocol on skin of NMRI mice, e.g. RPA when used instead of the promoter TPA is essentially a non-promoter (1 9,48). This property may be used to subdivide operationally the stage of promotion in two substages (48, 72) called 'conversion' stage (6) and 'propagation' stage (PI and PI1 in Fig. 1, respectively) . To verify such protocol in conjunction with an initiating dose i of DMBA, as usual in our initiation-promotion protocol, the initiating dose i has to be followed by at least one single dose p of TPA (substage PI) and subsequently by multiple doses of RPA (substage PII). The two substages ofpromotion thus defined may be most useful in separating promotion-specific biochemical events, confined essentially to substage PI ('conversion'), from non-specific biochemical events confined essentially to substage PI1 ('propagation'). In view of the biological and the biochemical pleiotropism of irritant promoters of the DTE type, it is difficult to pinpoint their promotion specific biochemical events (29-3 1) and efforts in this area are most important for further successful molecular analysis of the promotion stage (36, 46, 54) . Despite its usefulness in niecliaiiistic investigations, the subdivision of the promotion stage does not require to revise-as proposed (46)-the etiologicdefinition ofcocarcinogens of the promotoer type (25) (26) (27) 32) .
The synopsis of all data available so far on structure-activity relationships of DTE shows that both principal structural elements, the ester and diterpene moieties, are essential for bioactivity. The pronounced hydrophilic-lipophilic nature of promoting FIG. 6.-Total and specific binding of 3H-PDPr to particulate fraction of mouse epidermis (A) and of 3H-TPA to particulate fraction of mouse brain (B), corresponding Scatchard plots with dissociation contant K, and receptor density R,.
DTE suggest that their Specific target molecules may be located in cellular membranes (23,30, 3 1). This hypothesis was validated by experimental studies on the specific binding of ultimate promoters to cellular structures.
Uiispeccific and Spec@ Non-Coidetit Bittding of
Ultiiiiate Pronioters to Meiiibraiie Associated Receptors. In attempts to find inhibitors of TPA-induced promotion which are capable of competing with the TPA for specific binding sites, phorbol-12,13-diproprionate (PDPr) was shown to be optimal as an inhibitor aird non-promoter (30, 3 1, 64). Therefore, (20JH)PDPr was used as a radioligand to load the particulate fiactioit of itioiise epidermis (62, 65) . It was found that a considerable portion ofthe total binding capacity for the radioligand provides for specific binding (Fig. 6a ). In this system the specific (20JH)PDPr binding may be inhibited by non-labeled PDPr and other DTE. This is shown in Table IV by their inhibition coefficients Ki, and complemented by the imtancies and promoting activities of the particular DTE. With (20-3H)PDBu as an alternate radioligand (1 3), independently similar results'were.obtained as with (20JH)PDPr.
An even more direct approach to specific agonistreceptor binding may be provided by use of (20-3H)TPA as radioligand versus non-labeled TPA and other DTE as competitors ( Fig. 6b) (37, 38) . Investigations of tissue distribution of specific binding sites showed that mouse brain provides the highest receptor density per mg of DNA (15, 38) . Specific binding of labeled ingenob3-ester prototype (20-3H)3-TI to the particulate fraction of mouse brain was also demonstrated recently (unpublished observations).
The low, hormone-like dose levels at which the irritant, hyperplasiogenic and initiation-promoting DTE bind specifically to inenibrane binding sites suggest that these sites may be related to or are identical with specific receptors triggering single key enzymes or enzymatic cascades which govern the biochemical and biological effects elicited by DTE, such as DNA and phospholipid. biosynthesis in mouse epidermis. Many more effects have been detected since (Table V) (29-3 1) . The putative physiological endogenous ligands or true agonists of such receptors are unknown as yet; they may be certain hormones or growth factors (23, 70) .
At this stage, the problem of DTE receptors became very much reminiscent of the pioneering investigations in opiate neurotransmitter receptors reported some time ago: the identification of the receptors for opiates preceded, and in some way predicted, the discovery of up to then unknown physiological endogenous opioid peptides as Iigands or true agonists. Thus, quite apart from the mechanistic implications of structure-activity relations of DTE promoters as discussed, they may provide certain additional clues for redesigning of certain DTEs to obtain new principles of anticancer drugs (33) . > 10-5 7.0 x 10-9 2.3 x 10-9 Inhibition coefficient Ki measured it1 vifro by release of 3H-PDPr bound specifically to mouse epidermal particulate fraction. In standard initiation-promotion protocol on dorsal skin of NMRI mice with i = 100 nmoles of DMBA. From synoptic evaluation (see ref. 76 ). Not tested. ID2. 14,30,3 1,39,63,75) . The former indicate a distinct molecular orientation of DTE in membranes with their lipophilic ester moiety anchored in the lipid bilayer (30, 3 1); the latter show the presence of certain phospholipids in the microenvironment of the DTE binding sites or receptors, especially phosphatidylserine and -ethanolamine (14,39,63) . They are known to be essential for bioactivity of the Ca++ dependent protein kinase C (PKC). Indeed, a considerable amount of indirect evidence was accumulated in several laboratories to indicate that PKC is a TPA receptor (9,  30,3 1,49,53) , particularly in mouse epidermis (22, 66). Conversely, it was shown that TPA and congeners activate PKC (9). Further, diacylglycerols (DG) are capable of competing with TPA for receptor binding and stimulate comparable cell functions as does TPA, albeit at very high concentrations.
D TE Receptors, the Iiiosit olph osph olipid/Diacyl-
With PKC in the role of a receptor, these findings suggest that DTE irritants and promoters intervene with the inositolphospholipid (IPL)-diacylglycerol (DG)-operated second messenger system (5, 30, 3 1,  49,53) . This system (Fig. 7) is associated with membrane-associated receptors of (a) eridocrirte prolif- (Table V) . It remains to be seen if and how any of the biochemical cascades known to be triggered by phorbol esters is associated with regular gene amplification or with gene transposition, as putative, mechanistic key elements of promotion provided specifically by initiated in contrast to normal cells. In this context, it is of interest that some lines of the mouse epidermal cell strain JB 6 respond to TPA and gain anchorage independence and malignancy (P+), while others (P-) fail to respond (12). These lines can be used to search for biochemical membrane-associated differences: (P+) cells were found to lack stimulated hexose transport, binding to epidermal growth factor-receptor and susceptibility to mitogenic stimulation. Surprisingly, (P-) cells contained specific phorbol ester receptors. It was assumed that these do not control those biochemical functions required for manifestation of neoplastic transformation, but rather other basic cellular functions. A decrease in the synthesis of plasma membrane trisialoganglioside is induced by TPA in all (P+) cells tested, but in none of the (P-) cell lines. Another event possibly involved in the promotion of iiz vitru transformed cells appears to be a specific loss of collagen synthesis associated with a deficiency of translatable and hybridizable collagen m-RNA, as shown in (P-) cells. (P+) properties can be transfected into (P-) cells by isolated and purified (P+) DNA.
An interesting set of data from Table IV indicates a possible multiplicity of DTE receptors (40): the highly irritant however incomplete (or PII) promoters RPA and milliamine C inhibit (20JH)PDPr binding with a K, of about one order of magnitude higher than that of complete (or PI) promoters, such as TPA. This finding may indicate the presence of two different types of receptors: one type interacting with PI promoters and mediating biochemical events specific for promotion, while the other, responsive to PI1 promoters, mediates less specific biochemical events, such as hyperplasiogenic activity. Therefore, one possible approach to develop the problem of identification of promoter specific events may be a further clarification of the role of complete (PI) and incomplete (PII) promoters in the initiation-promotion model (28-3 1). Stimulation by DTE ofvirus specific proteins in cells containing latent episomal or integrated viral genomes may be indicative of promoter-specific key events provided by the initiated cell. It may be postulated that complete promoters, such as TPA and other DTE, provide certain types of chromosomal damage as specific promotional events seen with TPA but not with RPA (16, 17, 21). These clastogenic effects may be brought about by activation of oxygen radicals and play a key role (10, 45). Damages of this kind may thus constitute the first or conversion stage of promotion (PI) (Fig. 1 ). The second, or propagation stage, would provide the mitogenic stimulus, either by means of RPA and other mitogens, to propagate the compartment of converted cells. In such a proposition, PI would operate at the genomic and PII, at least, partly at the epigenomic level.
On the background of the findings presented and of the hypotheses discussed, a great variety of experimental challenges may be devised to pinpoint those specific molecular events critical for promotion of initiated cells.
CONCLUSIONS
The experimental initiation-promotion-progression model of mouse skin chemical carcinogenesis, operated by DMBA as initiator and by DTE promoters, has been developed to the extent that speat SAGE PUBLICATIONS on December 9, 2012 tpx.sagepub.com Downloaded from cific molecular mechanisms may be postulated for initiation and promotion stages. Many of the other multistage models, involving other target tissues as well as other initiators and promoters (liver, bladder) still require precise definition of the experimental protocol with regard to the stages involved, i.e. with regard to sub-carcinogenic and sub-promotional doses. It remains to be seen to what extent molecular events demonstrated in the stages of the mouse skin model are applicable to the stages of other models. Especially for the stage of promotion, it is an open question if a common molecular or biological denominator exists, responsible for promotion, independent of the specific model or tissue involved. Evaluations of this aspect are urgent, in view of the need to provide appropriate short term assays to detect tumor promoters as risk factors of cancer in man (29) .
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